You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.



How Has COVID-19 Impacted Pediatric and Adolescent Mental Health?

  • Authors: Tristin D. Abair, PhD
  • CME / ABIM MOC / CE Released: 3/10/2023
  • Valid for credit through: 3/10/2024
Start Activity

  • Credits Available

    Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.25 ABIM MOC points

    Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Pharmacists - 0.25 Knowledge-based ACPE (0.025 CEUs)

    IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for psychiatrists, neurologists, nurse practitioners, primary care physicians, pediatricians, physician assistants, nurses, pharmacists, and other healthcare professionals who provide care to pediatric patients with neuropsychiatric disorders.

The goal of this activity is for learners to be better able to evaluate risks and protective factors that can influence mental health and well-being of patients and engage in team-based approaches to further enhance treatment and outcomes in patients.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Impact of the COVID-19 pandemic on the prevalence of and risks for behavioral health disorders in pediatric and adolescent patients
    • Approaches to improve the management of neuropsychiatric disorders in pediatric and adolescent patients
  • Demonstrate greater confidence in their ability to
    • Incorporate interprofessional strategies into pediatric and adolescent psychiatric care


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


  • Tristin D. Abair, PhD

    Senior Medical Writer
    Medscape, LLC


    Tristin D. Abair, PhD, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-23-100-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit(s)™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


How Has COVID-19 Impacted Pediatric and Adolescent Mental Health?

Authors: Tristin D. Abair, PhDFaculty and Disclosures

CME / ABIM MOC / CE Released: 3/10/2023

Valid for credit through: 3/10/2024



  1. Centers for Disease Control and Prevention (CDC). COVID data tracker. Accessed February 15, 2023.
  2. Leeb RT, et al. Mental health-related emergency department visits among children aged < 18 years during the COVID-19 pandemic -- United States, January 1-October 17, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1675-1680.
  3. Racine N, et al. Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis. JAMA Pediatr. 2021;175:1142-1150.
  4. Gupta RS, et al. Neural markers of emotion regulation difficulties moderate effects of COVID-19 stressors on adolescent depression. Depress Anxiety. 2022;39:515-523.
  5. Ali MM, et al. Mental health conditions among children and adolescents with a COVID-19 diagnosis. Psychiatr Serv. 2022;73:1412-1413.
  6. Chadi N, et al. COVID-19 and the impacts on youth mental health: emerging evidence from longitudinal studies. Can J Public Health. 2022;113:44-52.
  7. Cunning C, et al. The COVID-19 pandemic and obsessive-compulsive disorder in young people: systematic review. Clin Child Psychol Psychiatry. 2022;27:18-34.
  8. Buonsenso D, et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110:2208-2211.
  9. Mazza MG, et al. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. 2022;36:681-702.
  10. Fotuhi M, et al. Neurobiology of COVID-19. J Alzheimers Dis. 2020;76:3-19.
  11. Cataldi M, et al. Neurobiology of coronaviruses: potential relevance for COVID-19. Neurobiol Dis. 2020;143:105007.
  12. Santibañez L, et al. The effects of absenteeism on academic and social-emotional outcomes: lessons for COVID-19. Educ Res. 2021;50:391-400.
  13. Magson NR, et al. Risk and protective factors for prospective changes in adolescent mental health during the COVID-19 pandemic. J Youth Adolesc. 2021;50:44-57.
  14. Li X, et al. Screen use and mental health symptoms in Canadian children and youth during the COVID-19 pandemic. JAMA Netw Open. 2021;4:e2140875.
  15. Nilsson A, et al. Gaming and social media use among adolescents in the midst of the COVID-19 pandemic. Nordisk Alkohol Nark. 2022;39:347-361.
  16. Ellis WE, et al. Physically isolated by socially connected: psychological adjustment and stress among adolescents during the initial COVID-19 crisis. Can J Behav Sci. 2020;52:177-187.
  17. Werling AM, et al. Media use before, during and after COVID-19 lockdown according to parents in a clinically referred sample in child and adolescent psychiatry: results of an online survey in Switzerland. Compr Psychiatry. 2021;109:152260.
  18. Liu SR, et al. The acute and persisting impact of COVID-19 on trajectories of adolescent depression: Sex differences and social connectedness. J Affect Disord. 2022;299:246-255.
  19. Lee J. Mental health effects of school closures during COVID-19. Lancet Child Adolesc Health. 2020;4:421.
  20. Loades ME, et al. Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and adolescents in the context of COVID-19. J Am Acad Child Adolesc Psychiatry. 2020;59:1218-1239.e3.
  21. Guessoum SB, et al. Adolescent psychiatric disorders during the COVID-19 pandemic and lockdown. Psychiatry Res. 2020;291:113264.
  22. Glynn LM, et al. A predictable home environment may protect child mental health during the COVID-19 pandemic. Neurobiol Stress. 2021;14:100291.
  23. Mitchell P, et al. Core principles & values of effective team-based health care. Accessed February 24, 2023.
« Return to: How Has COVID-19 Impacted Pediatric and Adolescent Mental Health?
  • Print